JAMA Otolaryngology is a member of the JAMA Network, a consortium of peer-reviewed publications.
24/07/2025
Meclizine is associated with a doubling of fall risk when provided to individuals after dizziness evaluation. https://ja.ma/3GPjNRl
23/07/2025
Acid suppression therapy was associated with a small increase in the utilization of supraglottoplasty in infants with non-severe laryngomalacia managed with watchful waiting. https://ja.ma/4f2Bsl3
22/07/2025
Over-the-counter (OTC)+ and OTC service models were effective but did not achieve the same outcomes as the audiologist service model in individuals with mild to moderate hearing loss. https://ja.ma/44VUe98
21/07/2025
Most viewed this week from JAMA Otolaryngology: A 17-year-old male with no significant medical history presented to his pediatrician with a 3-day history of sore throat and progressive shortness of breath. What is your diagnosis?
Eustachian tube balloon dilation showed no benefit for patients with measurable eustachian tube dysfunction undergoing tympanoplasty. https://ja.ma/3GAjhGO
20/07/2025
Cannabis use disorder was linked to a higher incidence of benign salivary gland tumors, particularly in the parotid gland, in this cohort study, suggesting site-specific effects. https://ja.ma/4lziCV2
19/07/2025
A healthy 69-year-old man with a painful, progressively enlarging ulcer located on the left buccal mucosa. What is your diagnosis? Take the Clinical Challenge. https://ja.ma/3IzAqkn
19/07/2025
Most viewed this week from JAMA Otolaryngology: A 17-year-old male with no significant medical history presented to his pediatrician with a 3-day history of sore throat and progressive shortness of breath. What is your diagnosis?
Transoral ultrasonography for evaluation of suspected oropharyngeal cancer provides higher diagnostic accuracy than MRI in the outpatient setting. https://ja.ma/411S1Yv
17/07/2025
Advanced cancer stage and receiving multiple treatment modalities were the strongest predictors of high health care costs in patients with head and neck cancer. https://ja.ma/3GI161S
16/07/2025
Patients who are post-op minimal residual disease (MRD)+ are at a higher risk of recurrence; MRD status approximately 2-3 weeks post-op may be useful in addition to pathologic factors to select patient candidacy for de-escalation. https://ja.ma/4lVNI9i
15/07/2025
Reclassifying each N category 1 stratum higher for imaging-detected extranodal extension-positive disease resulted in better disease-free and overall survival in patients. https://ja.ma/40Rx968
Be the first to know and let us send you an email when JAMA Otolaryngology—Head & Neck Surgery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.